Singapore-based Farrer Park Hospital introduces AI colorectal screening service

2022-06-14
合作
Farrer Park Hospital, a private tertiary care provider in Singapore, has started offering its latest AI-assisted colorectal screening service to improve its detection, classification, screening and monitoring of colorectal polyps and cancer. The hospital is using an AI screening tool which automatically alerts doctors in real-time of suspected lesions and polyps. The service was tried out between March and April when over 360 colonoscopies were done. It was officially introduced as a new hospital offering in May. WHY IT MATTERS Colorectal cancer is the leading cause of cancer deaths in Singapore, affecting around 1,800 people each year . FPH introduced its latest AI screening service to enable "more accurate detection of polyps," according to a press release. Dr Desmond Wai, a consultant gastroenterologist at FPH, said the technology helps reduce false negative results and avoids the risk of missing polyps by clearly highlighting them. "This improves the accuracy of the scopes conducted which are essential in a patient's health journey," he said. The use of AI is particularly useful for identifying flat and sessile polyps, which are often missed, noted Dr Chew Min Hoe, a senior consultant and colorectal surgeon at FPH. THE LARGER TREND In recent years, FPH has been turning to AI to improve its health services. In September last year, it reported employing an AI-enabled MRI screening tool for dementia to enhance dementia diagnosis. In November, the company partnered with Medtronic to launch its AI-assisted early screening service for cardiac diseases. The programme uses a digital auscultation device with ECG and AI from Medtronic which identifies missing sounds in patients' hearts that would otherwise go unnoticed.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。